Expresión diferencial de mirnas y sus posibles implicaciones en diversas enfermedades crónicas no transmisibles
datacite.rights | http://purl.org/coar/access_right/c_16ec | eng |
dc.contributor.advisor | Navarro Quiroz, Elkin | |
dc.contributor.author | Bello Valbuena, Keyla | |
dc.contributor.author | Bermúdez, Davidson Emil | |
dc.contributor.author | Martínez Suarez, Luis | |
dc.date.accessioned | 2024-03-18T15:45:00Z | |
dc.date.available | 2024-03-18T15:45:00Z | |
dc.date.issued | 2014 | |
dc.description.abstract | Los micrornas son biomarcadores moleculares expresados en el desarrollo de diversas enfermedades que sirven para predecir el curso de la enfermedad por lo tanto al conocer cada microRNAs podemos establecer un diagnóstico certero y un tratamiento eficaz ya que muchas patologías no responden a estos porque la sobreexpresión de los microRNAs juega un papel fundamental en la sensibilidad al tratamiento que se haya establecido. El propósito del presente trabajo es realizar una revisión en la literatura científica de asociaciones entre patrones diferenciales de micrornas y sus posibles implicaciones en diversas enfermedades crónicas no trasmisibles. Los micrornas como moduladores en procesos biológicos tanto directa como indirectamente juegan un papel fundamental en la respuesta al tratamiento que se le realice al paciente | spa |
dc.description.abstract | micrornas are molecular biomarkers expressed in the development of various diseases that can predict the course of the disease therefore knowing every microRNAs can establish an accurate diagnosis and effective treatment since many diseases do not respond to these because overexpression of microRNAs plays a key role in the sensitivity to treatment has been established. The purpose of this paper is to review the scientific literature of differential patterns of associations between microRNAs and their potential implications for a variety of chronic noncommunicable diseases. Micrornas as modulators in both direct and indirect biological processes play a major role in the response to treatment was performed to the patient | eng |
dc.format.mimetype | spa | |
dc.identifier.uri | https://hdl.handle.net/20.500.12442/14382 | |
dc.language.iso | spa | spa |
dc.publisher | Ediciones Universidad Simón Bolívar | spa |
dc.publisher | Facultad de Ciencias de la Salud | spa |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 Internacional | eng |
dc.rights.accessrights | info:eu-repo/semantics/restrictedAccess | eng |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | |
dc.subject | Micrornas | spa |
dc.subject | Mir | spa |
dc.subject | Mirnas | spa |
dc.subject | Oncomirs | spa |
dc.subject | Metastamirs | spa |
dc.subject | Oncogenen | spa |
dc.subject | Protooncogén | spa |
dc.subject | Expresión | spa |
dc.subject | Regulación | spa |
dc.title | Expresión diferencial de mirnas y sus posibles implicaciones en diversas enfermedades crónicas no transmisibles | spa |
dc.type.driver | info:eu-repo/semantics/bachelorThesis | eng |
dc.type.spa | Trabajo de grado - pregrado | spa |
dcterms.references | J Jiang, Fesler. miRNA: The New Frontier In Cancer Medicine. Future Med.Chem. (2013) 5(9), 983-985. | eng |
dcterms.references | Bandres E, Foncillas-Garcia J, miRNA y Cåncer. Gh Continuada. SeptiembreOctubre 2009. Vol. 8 N. 0 5 | spa |
dcterms.references | Ji j , Ph.D., Shi j M.D., Budhu A , Ph.D .MicroRNA. Expression, Survival, and Response to Interferon in Liver Cancer, n engl j med 361; 15 nejm.org october 8, 2009. | eng |
dcterms.references | Ji j , Ph.D., Shij M.D., A , Ph.D .MicroRNA. Expression, Survival, and Response to Interferon in Liver Cancer, n engl j med 361; 15 nejm.org october 8, 2009. | eng |
dcterms.references | B. Dogini D Simoni Avansinia H, Rossi Torres F, MicroRNA Expression Profile in Epilepsy: Breaking Molecular Barriers, J Epilepsy Clin Neurophysiol | eng |
dcterms.references | Anguloa b M, Lecuonaa E, y lasha Sznajder J, Rol de los microARN en las enfermedades pulmonares AJ Jiang, Fesler. miRNA: the new frontier in cancer medicine. Future Med.Chem. (2013) 5(9), 983—985. | eng |
dcterms.references | Ji j , Ph.D., Shi j M.D., Budhu A , Ph.D .MicroRNA. Expression, Survival, and Response to Interferon in Liver Cancer, n engl j med 361; 15 nejm.org october 8, 2009. | eng |
dcterms.references | Marcucci G, M.D., Radmacher M, Ph.D, MicroRNA Expression in Cytogenetically Normal Acute Myeloid Leukemia, n engl j med 358; 18 www.nejm.org may 1, 2008 | eng |
dcterms.references | Adrian Calin G, M.D., Ph.D., Ferracin M, Ph.D., A MicroRNA Signature Associated with Prognosis and Progression in Chronic Lymphocytic Leukemia, n engl j med 353; 17 www.nejm.org october 27, 2005 | eng |
dcterms.references | RJ B, Pawlowski2 T, Catt03 J, Changes in circulating levels associated with prostate cancer, British Journal of Cancer (2012) 106, 768 — 774 & 2012 Cancer Research UK All rights reserved 0007 - 0920/12 | eng |
dcterms.references | R. Oakl S, Murray2 L, Herath2 A , Sleeman2 M; A Micro RNA Processing Defect in Rapidly Progressing Idiopathic Pulmonary Fibrosis; June 2011 | Volume 6 | Issue 6 | e21253 | eng |
dcterms.references | Wang J, Zhao J, Shi M, Ding Y, Sun H, et al. (2014) Elevated Expression of miR-210 Predicts Poor Survival of Cancer Patients: A Systematic Review and Meta-Analysis PL0S ONE e89223. doi:10.1371/journal.pone.0089223.Roderburg1 C, Mollnowl T, Bongaerts2 B; Micro-RNA Profiling in Human Serum Reveals Compartment-Specific Roles of miR-571 and miR-652 in Liver Cirrhosis, March 2012 | Volume 7 | Issue 3 | e32999 | eng |
dcterms.references | Chu D, Zhao Z, Li Y, Li J, Zheng J, et al. (2014) Increased MicroRNA-630 Expression in Gastric Cancer Is Associated with Poor Overall Survival. PLoS ONE 9(3): e90526. doi:10.1371/journal.pone.0090526 | eng |
dcterms.references | Wang J, Zhao J, Shi M, Ding Y, Sun H, et al. (2014) Elevated Expression of miR-210 Predicts Poor Survival of Cancer Patients: A Systematic Review and Meta-Analysis. Pi-os ONE 9(2): e89223. doi:10.1371/journal.pone.0089223 | eng |
dcterms.references | Schrauder1,2 G. M, Strickl R, Schulz-Wendtland3 R, Circulating MicroRNAs as Potential Blood-Based Markers for Early Stage Breast Cancer Detection, January 2012 | Volume 7 | Issue 1 | e29770 | eng |
dcterms.references | R. Oakl S, Murray2 L, Herath2 A , Sleeman2 M; A Micro RNA Processing Defect in Rapidly Progressing Idiopathic Pulmonary Fibrosis; June 2011 | Volume 6 | Issue 6 | e21253 | eng |
dcterms.references | Ferna'ndez-Velasc01 ,2* M, Priet02 P , Terro' n2 V , NODI Activation Induces Cardiac Dysfunction and Modulates Cardiac Fibrosis and Cardiomyocyte Apoptosis, September 2012 | Volume 7 | Issue 9 | e45260, | eng |
dcterms.references | R. Oakl S, Murray2 L, Herath2 A , Sleeman2 M; A Micro RNA Processing Defect in Rapidly Progressing Idiopathic Pulmonary Fibrosis; June 2011 | Volume 6 | Issue 6 | e21253 Otaeguil* D, Baranzini2 E. S, Arman- anzas R Differential Micro RNA Expression in PBMC from Multiple Sclerosis Patients, July 2009 | Volume 4 | Issue 7 | e6309 | eng |
dcterms.references | Saif Zaman M, Shahryari V, Deng G, Up-Regulation of MicroRNA-21 Correlates with Lower Kidney Cancer Survival, February 2012 | Volume 7 | Issue 2 | e31060. Anguloa b M, Lecuonaa E, y lasha Sznajder J, Rol de los en las enfermedades pulmonares AJ Jiang, Fesler. miRNA: the new frontier in cancer medicine. Future Med.Chem. (2013) 5(9), 983-985. | eng |
oaire.version | info:eu-repo/semantics/acceptedVersion | eng |
sb.programa | Medicina | spa |
sb.sede | Sede Barranquilla | spa |
Archivos
Bloque original
1 - 1 de 1
No hay miniatura disponible
- Nombre:
- PDF.pdf
- Tamaño:
- 22.29 MB
- Formato:
- Adobe Portable Document Format